## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.6% in lower entry zone (4.0-10.0%), top quartile (78th pct) cross-sectional ranking. Caution: MRS_5 (-0.8%) diverging from MRS_20, watch for reversal. Outperforming sector by 6.0%. Caution: momentum weakening (-3.6% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($421.97)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 9)

**1. Synopsys Stock (SNPS) After Hours on Dec. 15, 2025: What Happened After the Close and What to Watch Before Tuesdayâ€™s Open**
- Source: ts2.tech | 20251216T020814 | Neutral | Relevance: 100%
- Synopsys (SNPS) experienced a slight gain in Monday's regular session but traded lower after-hours due to a volatile tech market, new ratings commentary, and ongoing class-action notices. Key factors include the broader market's reaction to incoming economic data, the integration of Ansys, workforce restructuring, and a securities class action. Investors are advised to monitor Synopsys' after-hours dip, macroeconomic indicators, and the company's FY2026 targets and annual report filing.

**2. Synopsys, Inc. (SNPS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit**
- Source: Morningstar | 20251216T000840 | Bearish | Relevance: 100%
- The Law Offices of Frank R. Cruz announced that investors who suffered losses in Synopsys, Inc. (SNPS) have an opportunity to lead a securities fraud class action lawsuit. The lawsuit alleges that Synopsys failed to disclose how its increased focus on AI customers was negatively impacting its Design IP business, leading to misleading statements about the company's prospects. Investors who suffered losses between December 4, 2024, and September 9, 2025, are encouraged to participate before the December 30, 2025, lead plaintiff deadline.

**3. SNPS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit**
- Source: WANE 15 | 20251215T170855 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS), alleging the company made materially false and misleading statements about its business, operations, and prospects. The lawsuit, filed on behalf of investors who purchased Synopsys securities between December 4, 2024, and September 9, 2025, claims the company failed to disclose how its focus on AI customers negatively impacted its Design IP business economics. Investors who suffered losses have until December 30, 2025, to request to be appointed as lead plaintiff.

**4. Synopsys, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - SNPS**
- Source: Morningstar | 20251215T140845 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Synopsys, Inc. (NASDAQ: SNPS) regarding alleged securities law violations. The lawsuit claims that Synopsys made materially false and/or misleading statements concerning the economic impact of its increased focus on AI customers on its Design IP business. Shareholders who purchased SNPS shares between December 4, 2024, and September 9, 2025, are encouraged to contact the firm by the December 30, 2025 deadline to explore lead plaintiff appointment.

**5. Levi & Korsinsky Notifies Synopsys, Inc. (SNPS) Shareholders of Class Action Lawsuit and December 30, 2025 Deadline**
- Source: KXAN Austin | 20251215T130855 | Bearish | Relevance: 100%
- Levi & Korsinsky has announced a class action lawsuit against Synopsys, Inc. (SNPS) on behalf of shareholders who suffered losses due to alleged securities fraud between December 4, 2024, and September 9, 2025. The lawsuit claims that Synopsys made false statements and concealed information regarding the negative impact of its increased focus on AI customers on its Design IP business and financial results. Shareholders are encouraged to learn about their potential recovery rights before the December 30, 2025 deadline.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.54M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.3x requires aggressive growth execution.
2. Long-term trend broken: trading 6.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 6.26 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Insider buying signal ($0.5M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $86.6B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.26 |
| Forward P/E | 26.8 |
| Current P/E | 31.6 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 9.1% to 5.6% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 78th percentile. MRS_5 (-0.8%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.2% shows strong absolute momentum above own 20MA. Outperforming sector by 6.0pp, stock-specific strength. Below SMA200 (0.93x), long-term trend not supportive. MACD histogram positive (4.21), confirming momentum. RSI neutral at 56. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.58% (CS: 78) | Strong |
| RSI_14 | 56.4 | Neutral |
| MACD Histogram | 4.21 | Bullish |
| vs SMA20 | 1.052x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 0.931x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $454.67
- **Stop Loss:** $421.97 (7.2% risk)
- **Target:** $503.72 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 30
- **Position Value:** $13,640.10
- **Portfolio %:** 13.64%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*